首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1085637

Clomiphene Citrate市場:各適應症，各流通管道，各地區-規模，佔有率，展望，機會分析-2022～2028年

Clomiphene Citrate Market, by Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月22日 | 出版商:

Coherent Market Insights | 英文 166 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

多囊性卵巢症候群的高發生率，是Clomiphene Citrate市場成長的主要促進因素。同時，本劑的副作用妨礙市場成長。

本報告提供全球Clomiphene Citrate市場相關調查分析，市場促進因素，阻礙因素，市場機會，各適應症、流通管道、地區市場分析，企業簡介相關資訊。

According to the data published in the National Institutes of Health (NIH) in January 2017, the most common overall cause of female infertility is the failure to ovulate, which occurs in 40% of women with infertility issues, globally. To treat such infertility problems in females, clomiphene citrate is the first choice of medicine for the past 40 years, according to the Global Library of Women's Medicine. Gynecologists prescribe clomiphene for 1 to 6 months or more with a low dose of 50 mg daily (1 tablet) for 5 days. If ovulation does not occur after the first course of therapy, a second course of 100 mg daily (two 50 mg tablets given as a single daily dose) for 5 days is prescribed.

According to a study called 'Clomiphene citrate usage pattern in India' conducted by Fertility Science and Research in 2014, ovulation rate was reported to increase from 21% to 60% and the pregnancy rate was noticed to be increased by 11% to 30% by majority of participants. The ovulation rate and pregnancy rate was increased using clomiphene citrate because of increased secretion of hypothalamic gonadotropin-releasing hormone (GnRH) to increase the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which will, in turn, stimulate ovarian follicular activity.

Market Dynamics

High incidence of polycystic ovarian syndrome is expected to be a key driver for the clomiphene citrate market growth. For instance, according to an article published in 2014 in Clinical Epidemiology, polycystic ovarian syndrome affects 8% to 20% of the reproductive-age women, globally. According to the World Health Organization, in 2012, polycystic ovarian syndrome affected 116 million women, worldwide.

The clomiphene citrate market growth is hindered by side effects shown by this drug, which includes headache, nausea, upper respiratory tract infection, abdominal tenderness, sinus congestion, mood swings, acne, breast tenderness, weight gain, pelvic discomfort, abnormal bleeding or spotting, vomiting, injection site pain, redness, dizziness, and ovarian hyper-stimulation syndrome (OHSS). For instance, according to a study published in NCBI, in 2016, 10% to 20% of women who consumed clomiphene citrate developed a mild form of OHSS, which will usually resolve on its own. Severe cases of OHSS occurred in less than one percent of patients in the U.S.

Key features of the study:

This report provides in-depth analysis of the global clomiphene citrate market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global clomiphene citrate market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Sanofi S.A., Par Pharmaceutical, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Serum Institute of India Pvt. Ltd., Incepta Pharmaceuticals Ltd., and Shanghai Trifecta Pharma Co. Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global clomiphene citrate market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for clomiphene citrate market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Clomiphene Citrate Market, By Indication:
- PCOS
- Secondary Amenorrhea
- Psychogenic Amenorrhea
- Amenorrhea Galactorrhea Syndrome
- Others
Global Clomiphene Citrate Market, By Distribution Channel::
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Clomiphene Citrate Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
  - By Indication:
- PCOS
- Secondary Amenorrhea
- Psychogenic Amenorrhea
- Amenorrhea Galactorrhea Syndrome
- Others
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
  - By Indication:
- PCOS
- Secondary Amenorrhea
- Psychogenic Amenorrhea
- Amenorrhea Galactorrhea Syndrome
- Others
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
  - By Indication:
- PCOS
- Secondary Amenorrhea
- Psychogenic Amenorrhea
- Amenorrhea Galactorrhea Syndrome
- Others
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
  - By Indication:
- PCOS
- Secondary Amenorrhea
- Psychogenic Amenorrhea
- Amenorrhea Galactorrhea Syndrome
- Others
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
  - By Indication:
- PCOS
- Secondary Amenorrhea
- Psychogenic Amenorrhea
- Amenorrhea Galactorrhea Syndrome
- Others
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
  - By Indication:
- PCOS
- Secondary Amenorrhea
- Psychogenic Amenorrhea
- Amenorrhea Galactorrhea Syndrome
- Others
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Company Profiles
- Sanofi S.A.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Par Pharmaceutical
- Merck & Co. Inc.
- Teva Pharmaceutical Industries Ltd.
- Cipla Inc.
- Unichem Laboratories Ltd.
- Emcure Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd.
- Incepta Pharmaceuticals Ltd.
- Shanghai Trifecta Pharma Co. Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Regulatory Scenario
Reimbursement Scenario
New Product Launches/Approvals
PEST Analysis
Impact Analysis of COVID-19 On Market
Clomiphene Citrate Usage Pattern
Prescription Algorithm And Insights
Pricing Analysis of Clomiphene Citrate

4. Global Clomiphene Citrate Market, By Indication, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
PCOS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Secondary Amenorrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Psychogenic Amenorrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Amenorrhea Galactorrhea Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Clomiphene Citrate Market, By Distribution Channel, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Clomiphene Citrate Market, By Region, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
Europe
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa

7. Competitive Landscape

Company Profiles
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Par Pharmaceutical
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Cipla Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Unichem Laboratories Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Emcure Pharmaceuticals Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Serum Institute of India Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Incepta Pharmaceuticals Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Shanghai Trifecta Pharma Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies

8. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

Clomiphene Citrate市場:各適應症，各流通管道，各地區-規模，佔有率，展望，機會分析-2022～2028年

Clomiphene Citrate Market, by Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目錄

第1章調查目的、前提條件

第2章市場概要

第3章市場動態，法規，及趨勢分析

第4章全球Clomiphene Citrate市場:各適應症(2017～2028年(100萬美元))

第5章全球Clomiphene Citrate市場:各流通管道(2017～2028年(100萬美元))

第6章全球Clomiphene Citrate市場:各地區(2017～2028年(100萬美元))

第7章競爭情形

第8章 Section

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Clomiphene Citrate Market, By Indication, 2017 - 2028, (US$ Million)

5. Global Clomiphene Citrate Market, By Distribution Channel, 2017 - 2028, (US$ Million)

6. Global Clomiphene Citrate Market, By Region, 2017 - 2028, (US$ Million)

7. Competitive Landscape

8. Section

Clomiphene Citrate市場:各適應症，各流通管道，各地區-規模，佔有率，展望，機會分析-2022～2028年

Clomiphene Citrate Market, by Indication, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

目錄

第1章 調查目的、前提條件

第2章 市場概要

第3章 市場動態，法規，及趨勢分析

第4章 全球Clomiphene Citrate市場:各適應症(2017～2028年(100萬美元))

第5章 全球Clomiphene Citrate市場:各流通管道(2017～2028年(100萬美元))

第6章 全球Clomiphene Citrate市場:各地區(2017～2028年(100萬美元))

第7章 競爭情形

第8章 Section

Market Dynamics

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Clomiphene Citrate Market, By Indication, 2017 - 2028, (US$ Million)

5. Global Clomiphene Citrate Market, By Distribution Channel, 2017 - 2028, (US$ Million)

6. Global Clomiphene Citrate Market, By Region, 2017 - 2028, (US$ Million)

7. Competitive Landscape

8. Section

第1章調查目的、前提條件

第2章市場概要

第3章市場動態，法規，及趨勢分析

第4章全球Clomiphene Citrate市場:各適應症(2017～2028年(100萬美元))

第5章全球Clomiphene Citrate市場:各流通管道(2017～2028年(100萬美元))

第6章全球Clomiphene Citrate市場:各地區(2017～2028年(100萬美元))

第7章競爭情形